
KEYNOTE – D36: personalized immunotherapy with a neoepitope vaccine, EVX-01 and pembrolizumab in advanced melanoma
Author(s) -
Georgina V. Long,
Pier Francesco Ferrucci,
Adnan Khattak,
Tarek Meniawy,
Patrick A. Ott,
Michael Chisamore,
Thomas Trolle,
A. Hyseni,
Erik D. Heegaard
Publication year - 2022
Publication title -
future oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.857
H-Index - 72
eISSN - 1744-8301
pISSN - 1479-6694
DOI - 10.2217/fon-2022-0694
Subject(s) - pembrolizumab , medicine , clinical trial , immunotherapy , melanoma , oncology , metastatic melanoma , ipilimumab , cancer research , cancer